Atlas Trials

Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition

Clinical trial NCT01735370 · COMPLETED

Trial details

NCT number
NCT01735370
Sponsor
IPCA Laboratories Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fasting
Start date
2012-05-01
Primary completion
2012-07-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.